Literature DB >> 30611451

Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study.

Lorenzo Loffredo1, Vincenzo Arienti2, Gianpaolo Vidili3, Chiara Cogliati4, Simona Battaglia1, Ludovica Perri1, Rosella Di Giulio2, Sciaila Bernardini5, Maria Luna Summa5, Angela Sciacqua6, Francesco Perticone6, Maria Boddi7, Giovanni Di Minno8, Corrado Lodigiani9, Antonello Pietrangelo10, Alessio Farcomeni11, Francesco Violi12.   

Abstract

OBJECTIVE: To evaluate the effect of hospitalization on deep venous thrombosis (DVT) rate by the cumulative incidence of DVT in the proximal venous tract of the lower limbs at admission and discharge.
METHODS: The AURELIO (rAte of venoUs thRombosis in acutEly iLl patIents hOspitalized in internal medicine wards) multicenter observational study was carried out in hospital-university internal medicine wards including consecutive acutely ill medical patients. Patients underwent compression ultrasonography (CUS) of proximal lower limb veins at admission and discharge. The occurrence of DVT was the primary end point of the study.
RESULTS: Among 1340 patients, 26 (1.9%; 95% CI, 1.3%-2.8%) had asymptomatic DVT at admission and were excluded. During the follow-up, 144 patients were excluded because of hospitalization less than 5 days. The remaining 1170 patients underwent a CUS at discharge. Two hundred fifty (21%) underwent prophylaxis with parenteral anticoagulants; the remaining 920 (79%) were not treated with anticoagulants. The mean length of hospitalization was 13±8 days. Compared with patients without prophylaxis, those treated with parenteral anticoagulants had a higher incidence of active cancer, heart and respiratory failure, pneumonia, renal failure, previous venous thromboembolism, reduced mobility, and elderly age. During the hospital stay, 3 patients with a negative CUS at admission experienced DVT in the proximal tract (0.025%, rate of 1 per 5017 patient-days); 2 of them were in prophylaxis with parenteral anticoagulants.
CONCLUSION: We provide evidence that in the real world acutely ill medical patients display more than 90% (1.9%) asymptomatic DVT at admission, whereas the intrahospital DVT occurrence is very low. This suggests a novel diagnostic workup and a careful reanalysis of anticoagulant prophylaxis.
Copyright © 2018 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30611451     DOI: 10.1016/j.mayocp.2018.07.020

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  6 in total

1.  Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge.

Authors:  Francesco Violi; Daniele Pastori; Roberto Cangemi; Pasquale Pignatelli; Lorenzo Loffredo
Journal:  Thromb Haemost       Date:  2020-04-29       Impact factor: 5.249

2.  Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection.

Authors:  Roberto Castelli; Antonio Gidaro
Journal:  J Hematol       Date:  2020-04-23

3.  Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?

Authors:  Marco Cattaneo; Elena M Bertinato; Simone Birocchi; Carolina Brizio; Daniele Malavolta; Marco Manzoni; Gesualdo Muscarella; Michela Orlandi
Journal:  Thromb Haemost       Date:  2020-04-29       Impact factor: 5.249

4.  Incidence and Predictors of Recurrence and Mortality Following First Venous Thromboembolism Among the Saudi Population: Single-Center Cohort Study.

Authors:  Fahad A S AlEidan; Reem K AlManea; Alyah T AlMoneef; Nada A Shalash; Norah A AlRajhi; Sarah F AlMousa; Abdulrahman Al Raizah; Khadega A Abuelgasim
Journal:  Int J Gen Med       Date:  2022-09-28

5.  Ultrasound screening for asymptomatic deep vein thrombosis in critically ill patients: a pilot trial.

Authors:  Giordano Tini; Amanda Moriconi; Stefano Ministrini; Valentina Zullo; Elisa Venanzi; Giulia Mondovecchio; Tommaso Campanella; Ettore Marini; Maura Bianchi; Federico Carbone; Matteo Pirro; Edoardo De Robertis; Leonella Pasqualini
Journal:  Intern Emerg Med       Date:  2022-08-31       Impact factor: 5.472

6.  High prevalence of early asymptomatic venous thromboembolism in anticoagulated COVID-19 patients hospitalized in general wards.

Authors:  Sylvain Le Jeune; Jaehyo Suhl; Ruben Benainous; François Minvielle; Christine Purser; Farid Foudi; Ursula Warzocha; Robin Dhote
Journal:  J Thromb Thrombolysis       Date:  2021-04       Impact factor: 2.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.